Stock OPTOMED OPTOMED OYJ
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Optomed Oyj

Equities

OPTOMED

FI4000410881

Market Closed - Nasdaq Helsinki
Other stock markets
 11:29:39 2024-05-10 EDT 		5-day change 1st Jan Change
5.47 EUR +2.05% Intraday chart for Optomed Oyj +10.62% +47.24%
05-07 Transcript : Optomed Oyj, Q1 2024 Earnings Call, May 07, 2024
05-07 Optomed Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Optomed Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Optomed USA, Inc. Introduces Optomed Aurora AEYE
CI
Optomed Oyj, AEYE Health say portable device to detect eye issues gets FDA nod
RE
Optomed Plc Announces Optomed Aurora with AEYE Receives U.S. Food & Drug Administration Clearance in US
CI
Optomed Plc Provides Revenue Guidance for the Full Year of 2024
CI
Optomed Oyj Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Optomed Oyj Provides Revenue Guidance for the Full Year 2024
CI
Optomed Oyj Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Optomed Oyj Provides Revenue Guidance for the Year 2023
CI
Optomed Oyj Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Optomed to Supply Large Diabetic Retinopathy Screening Solution to Spain
CI
Optomed Oyj Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Finland's Optomed Enters Distribution Partnership Deal With Thirona Retina
MT
Optomed Oyj Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Optomed Plc Provides Revenue Guidance for the Full Year 2023
CI
Optomed Oyj Provides Revenue Guidance for the Full Year of 2023
CI
Optomed Oyj Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
CI
Optomed Oyj Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Optomed Oyj Updates Earnings Guidance for the Full Year 2022
CI
Optomed Oyj Provides Revenue Guidance for the Year 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OPTOMED Stock
  4. News Optomed Oyj
  5. Highlights
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW